Molecular Surgeon Symposium on Pancreatic Cancer

描述（由申请人提供）：分子外科研讨会将汇集选定科学领域的活跃研究人员，目的是在互动环境中定义和分析重要的科学问题和最新进展。2003年胰腺癌分子外科研讨会将于2003年6月在德克萨斯州休斯顿的贝勒医学院举行。本次研讨会是为数不多的提供广泛介绍和讨论胰腺癌研究最新分子进展的论坛之一。2003年研讨会将包括开幕主题演讲和以下科学会议：1)。转录因子、细胞增殖、迁移和凋亡；2）. 生长因子、激素、受体、信号转导通路- i；3)。生长因子、激素、受体、信号转导通路- ii；4)。基因和分子标记- 1；5)。基因和分子标记- ii；6)。疫苗，基因和分子治疗，最后7)。胰腺癌研究的结束语——从实验室到临床。所有会议参与者将被邀请提交一份摘要到研讨会的海报部分，以便所有与会者，特别是学生，外科住院医师，博士后研究员和年轻研究者，展示数据并充分参与讨论。本次研讨会将汇集不同的学术科学家群体，他们的兴趣范围从研究胰腺癌发病机制的基础研究人员到对分子治疗和理解胰腺疾病感兴趣的内科科学家。有限的出席人数，重点科学会议和非常成功的海报会议相结合，为思想交流提供了一个令人兴奋的论坛，并为对胰腺癌感兴趣的不同群体的科学家提供了广泛的参与机会。

DESCRIPTION (provided by applicant): The Molecular Surgeon Symposium will bring together active researchers in a selected scientific field with the purpose of defining and analyzing important scientific problems and recent advances in an interactive environment. The 2003 Molecular Surgeon Symposium on Pancreatic Cancer will be held at the Baylor college of Medicine, Houston, Texas, in June 2003. This symposium is one of the few that provides a forum for presentation and discussion of a broad spectrum of the latest molecular advances in pancreatic cancer research. The 2003 symposium will consist of an opening keynote presentation with the following scientific sessions: 1). Transcription factors, cell proliferation, migration, and apoptosis; 2). Growth factors, hormones, receptors, signal transduction pathways-I; 3). Growth factors, hormones, receptors, signal transduction pathways-II; 4). Genes, and molecular markers-I; 5). Genes, and molecular markers-II; 6). Vaccine, gene and molecular therapy, and finally 7). Closing remarks on the pancreatic cancer research-from bench to bedside. All meeting participants will be invited to submit an abstract to the poster section planned for the symposium that allows all attendees, especially students, surgical residents, postdoctoral fellows, and young investigators, to present data and fully participate in discussions. This symposium will bring together a diverse group of academic scientists with interests ranging from basic researchers studying molecular mechanisms of pancreatic cancer pathogenesis, to physician-scientists interested in molecular therapies and in understanding pancreatic diseases. The limited attendance, focused scientific sessions, and highly successful poster session combine to provide an exciting forum for the exchange of ideas and to provide extensive opportunities for participation by a diverse group of scientists interested in pancreatic cancer. At the conclusion of the symposium, participants should be able to: 1) understand the impact of molecular biology technology for pancreatic cancer research; 2) discuss recent scientific advances related to molecular pathogenesis, diagnosis, and therapy for pancreatic cancer; 3) determine the future directions of pancreatic cancer research; and 4) establish collaboration network of pancreatic cancer research. All talks will be video-taped and presented at our "The Molecular Surgeon" website for general public access. This website has been established since first symposium in 1999.